{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:41:29Z","timestamp":1768707689263,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.intimp.2008.01.016","type":"journal-article","created":{"date-parts":[[2008,3,3]],"date-time":"2008-03-03T20:34:28Z","timestamp":1204576468000},"page":"708-716","source":"Crossref","is-referenced-by-count":46,"title":["Modulation of adjuvant arthritis in the rat by 2-methoxyestradiol: An effect independent of an anti-angiogenic action"],"prefix":"10.1016","volume":"8","author":[{"given":"Andrew C.","family":"Issekutz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kusum","family":"Sapru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2008.01.016_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jbspin.2004.12.012","article-title":"Where do T cells stand in rheumatoid arthritis?","volume":"72","author":"Fournier","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2008.01.016_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pathophys.2005.07.011","article-title":"Animal models of rheumatoid arthritis and their relevance to human disease","volume":"12","author":"Kannan","year":"2005","journal-title":"Pathophysiology"},{"key":"10.1016\/j.intimp.2008.01.016_bib3","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.rhu.0000166673.34461.33","article-title":"Immunologic mechanisms in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Firestein","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.intimp.2008.01.016_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0889-857X(21)00932-7","article-title":"Progress in the understanding of inducible models of chronic arthritis","volume":"13","author":"Breedveld","year":"1987","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.intimp.2008.01.016_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0076-6879(88)62089-1","article-title":"Adjuvant arthritis","volume":"162","author":"Taurog","year":"1988","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.intimp.2008.01.016_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3109\/s10165-005-0412-z","article-title":"Mechanisms of bone loss in rheumatoid arthritis","volume":"15","author":"Findlay","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.intimp.2008.01.016_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2004.12.013","article-title":"Cartilage breakdown in rheumatoid arthritis","volume":"73","author":"Rannou","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2008.01.016_bib8","doi-asserted-by":"crossref","first-page":"ii60","DOI":"10.1136\/ard.62.suppl_2.ii60","article-title":"Angiogenesis as a target in rheumatoid arthritis","volume":"62","author":"Koch","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.intimp.2008.01.016_bib9","first-page":"557","article-title":"Angiogenesis in rheumatoid arthritis","volume":"21","author":"Maruotti","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.intimp.2008.01.016_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543784.14.1.1","article-title":"New antiangiogenic strategies for the treatment of proliferative synovitis","volume":"14","author":"Lainer","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.intimp.2008.01.016_bib11","first-page":"1182","article-title":"Anti-adjuvant arthritis of recombinant human endostatin in rats via inhibition of angiogenesis and proinflammatory factors","volume":"25","author":"Yue","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.intimp.2008.01.016_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/cimm.1994.1223","article-title":"Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol","volume":"157","author":"Oliver","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.intimp.2008.01.016_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI3756","article-title":"Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist","volume":"103","author":"Storgard","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2008.01.016_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/368237a0","article-title":"The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth","volume":"368","author":"Fotsis","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2008.01.016_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0960-0760(03)00269-3","article-title":"The effects of 2-methoxy oestrogens and their sulphamoylated derivatives in conjunction with TNF-alpha on endothelial and fibroblast cell growth, morphology and apoptosis","volume":"86","author":"Ho","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.intimp.2008.01.016_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/bbrc.1998.8902","article-title":"2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and beta-galactosidase expression in vascular endothelial cells","volume":"248","author":"Tsukamoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2008.01.016_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1026543018478","article-title":"2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate","volume":"19","author":"Pribluda","year":"2000","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.intimp.2008.01.016_bib18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s004320000233","article-title":"The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors","volume":"127","author":"Schumacher","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.intimp.2008.01.016_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-2006-939855","article-title":"2-Methoxyestradiol\u2014a new compound for cancer treatment","volume":"131","author":"Schumacher","year":"2006","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.intimp.2008.01.016_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4161\/cbt.5.1.2349","article-title":"Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors","volume":"5","author":"Dahut","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.intimp.2008.01.016_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.1780400120","article-title":"Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol","volume":"40","author":"Josefsson","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2008.01.016_bib22","first-page":"656","article-title":"Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat","volume":"64","author":"Issekutz","year":"1991","journal-title":"Lab Invest"},{"key":"10.1016\/j.intimp.2008.01.016_bib23","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/1529-0131(200106)44:6<1428::AID-ART238>3.0.CO;2-U","article-title":"E-selectin, but not P-selectin, is required for development of adjuvant-induced arthritis in the rat","volume":"44","author":"Issekutz","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.intimp.2008.01.016_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1189\/jlb.70.2.225","article-title":"Growth factor regulation of neutrophil-endothelial cell interactions","volume":"70","author":"Zhang","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.intimp.2008.01.016_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2249.1994.tb06574.x","article-title":"The role of tumour necrosis factor-alpha and IL-1 in polymorphonuclear leucocyte and T lymphocyte recruitment to joint inflammation in adjuvant arthritis","volume":"97","author":"Issekutz","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2008.01.016_bib26","doi-asserted-by":"crossref","unstructured":"Kurokawa A, Azuma K, Mita T, et al. 2-Methoxyestradiol reduces monocyte adhesion to aortic endothelial cells in ovariectomized rats. Endocr J in press (Electronic publication ahead of print).","DOI":"10.1507\/endocrj.K07E-034"},{"key":"10.1016\/j.intimp.2008.01.016_bib27","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1097\/01.ASN.0000031804.77546.F5","article-title":"2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy","volume":"13","author":"Tofovic","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.intimp.2008.01.016_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.vph.2006.05.007","article-title":"2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension","volume":"45","author":"Tofovic","year":"2006","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.intimp.2008.01.016_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.fjc.0000162765.89437.ae","article-title":"Estradiol metabolites attenuate renal and cardiovascular injury induced by chronic nitric oxide synthase inhibition","volume":"46","author":"Tofovic","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.intimp.2008.01.016_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/FJC.0b013e31802cb88e","article-title":"2-Methoxyestradiol and 2-ethoxyestradiol retard the progression of renal disease in aged, obese, diabetic ZSF1 rats","volume":"49","author":"Zhang","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.intimp.2008.01.016_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00001622-200311000-00004","article-title":"New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent","volume":"15","author":"Mooberry","year":"2003","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.intimp.2008.01.016_bib32","first-page":"468","article-title":"2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway","volume":"63","author":"LaVallee","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.intimp.2008.01.016_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/B:APPT.0000025809.80684.bd","article-title":"2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases","volume":"9","author":"Wood","year":"2004","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2008.01.016_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1196\/annals.1299.026","article-title":"TNFalpha potentiates 2-methoxyestradiol-induced mitochondrial death pathway","volume":"1010","author":"Djavaheri-Mergny","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.intimp.2008.01.016_bib35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bbrc.2004.07.204","article-title":"Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol","volume":"322","author":"Hagen","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.intimp.2008.01.016_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/35030140","article-title":"Superoxide dismutase as a target for the selective killing of cancer cells","volume":"407","author":"Huang","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2008.01.016_bib37","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2174\/0929867043365297","article-title":"Mitochondrial superoxide dismutase: a promising target for new anticancer therapies","volume":"11","author":"Pani","year":"2004","journal-title":"Curr Med Chem"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908000192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576908000192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T22:02:30Z","timestamp":1738101750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576908000192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1567576908000192"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2008.01.016","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}